SHANGHAI, March 19 (Reuters) - AstraZeneca said on Thursday it will build a cell therapy manufacturing and supply base and an ...
The company is establishing commercial production capabilities to fuel plans to launch autologous CAR-T cell therapies in ...
Following through with its sizable investment commitment in China, AstraZeneca on Thursday unveiled plans to build a ...
AstraZeneca (AZN) and Sanofi (SNY) have become the latest drugmakers in the West to expand R&D operations in China, a market ...
British pharma major AstraZeneca (LSE: AZN) is stepping up its China strategy with plans to build a commercial cell therapy ...
The planned Shanghai facility extends a yearslong push into the field and will support CAR-T therapies AstraZeneca is making ...
The FDA's cancer advisors will discuss AstraZeneca’s application for the oral SERD camizestrant in breast cancer and the AKT ...
French biotech Abivax has been the subject of intense takeover speculation for months. But a spokesperson denied a report by ...
AstraZeneca, a global, science-led biopharmaceutical company, has made available its treatment, Soliris®, in Malaysia as part ...
The EU approval of Imfinzi for early-stage gastric and gastroesophageal cancers expands the label of one of the company’s top ...
As AstraZeneca kicks off the third year of its hockey-themed “Get Body Checked Against Cancer” campaign, the pharma has tapped two celebs known for their work both on and off the ice. | As AstraZeneca ...
AstraZeneca said on Thursday it would build a cell therapy manufacturing and supply base and an innovation centre in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results